Position
ALGERT GLOBAL LLC in BridgeBio Pharma, Inc.
Back to the book · All holders of BBIO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$633$0.08 → $0.07
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 341K | $26.1K | — | — | — | 0.4% |
| Q1 2026 | 283.9K | $21.1K | $0.07 | −$633 | −$4.37K | 0.3% |